Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharine Floyd

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|February 27, 2024
CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartmentMeenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
CCR2-dependent monocyte-derived cells restrict SARS-CoV-2 infectionAbigail Vanderheiden, Jeronay Thomas, Allison L Soung, et al.
Virology|March 11, 2021
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from IndiaKaustuv Nayak, Kamalvishnu Gottimukkala, Sanjeev Kumar, et al.
Nature Immunology|November 30, 2023
BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistanceAudrey Lee, Katharine Floyd, Shengyang Wu, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantVenkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Nature Communications|June 12, 2021
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lungNanda Kishore Routhu, Narayanaiah Cheedarla, Venkata Satish Bollimpelli, et al.
Science Immunology|March 31, 2022
A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infectionNanda Kishore Routhu, Sailaja Gangadhara, Lilin Lai, et al.
NPJ Vaccines|May 23, 2022
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in miceLilit Grigoryan, Audrey Lee, Alexandra C Walls, et al.
Cell Reports. Medicine|March 2, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
Cell Reports|July 8, 2021
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|February 27, 2024
CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartmentMeenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
CCR2-dependent monocyte-derived cells restrict SARS-CoV-2 infectionAbigail Vanderheiden, Jeronay Thomas, Allison L Soung, et al.
Virology|March 11, 2021
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from IndiaKaustuv Nayak, Kamalvishnu Gottimukkala, Sanjeev Kumar, et al.
Nature Immunology|November 30, 2023
BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistanceAudrey Lee, Katharine Floyd, Shengyang Wu, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantVenkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Nature Communications|June 12, 2021
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lungNanda Kishore Routhu, Narayanaiah Cheedarla, Venkata Satish Bollimpelli, et al.
Science Immunology|March 31, 2022
A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infectionNanda Kishore Routhu, Sailaja Gangadhara, Lilin Lai, et al.
NPJ Vaccines|May 23, 2022
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in miceLilit Grigoryan, Audrey Lee, Alexandra C Walls, et al.
Cell Reports. Medicine|March 2, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
Cell Reports|July 8, 2021
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.
Pageof 4